Review



flow cytometric lymphocyte proliferation test method  (Ampath Laboratories)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Ampath Laboratories flow cytometric lymphocyte proliferation test method
    Flow <t>cytometric</t> gating strategies used to identify the response of T-cells to the N-protein and S-protein of SARS-CoV2. Gating was first set on singlet events (A), followed by gating on target populations, leucocytes (B) and then CD3 expressing T-cells (C). The stimulation of the T-cells were measured using intracellular—PE Ki-67 (D). Buffer was added to the negative control (unstimulated) in (D). The positive control in (E) was pokeweed mitogen. The stimulation of the T-cells can be seen in the <t>proliferation</t> gate (E). T-cell activation seen in the proliferation gate (F) when exposed to nucleocapsid (N) protein of SARS-CoV2. T-cell activation seen in the proliferation gate (G) when exposed to spike (S) protein of SARS-CoV2. SSC, side scatter.
    Flow Cytometric Lymphocyte Proliferation Test Method, supplied by Ampath Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/flow+cytometric+lymphocyte+proliferation+test+method/pmc08783969-63-2-13?v=Ampath+Laboratories
    Average 90 stars, based on 1 article reviews
    flow cytometric lymphocyte proliferation test method - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Comparison of T-cell immune responses to SARS-CoV-2 spike (S) and nucleocapsid (N) protein using an in-house flow-cytometric assay in laboratory employees with and without previously confirmed COVID-19 in South Africa: nationwide cross-sectional study"

    Article Title: Comparison of T-cell immune responses to SARS-CoV-2 spike (S) and nucleocapsid (N) protein using an in-house flow-cytometric assay in laboratory employees with and without previously confirmed COVID-19 in South Africa: nationwide cross-sectional study

    Journal: Journal of Clinical Pathology

    doi: 10.1136/jclinpath-2021-207556

    Flow cytometric gating strategies used to identify the response of T-cells to the N-protein and S-protein of SARS-CoV2. Gating was first set on singlet events (A), followed by gating on target populations, leucocytes (B) and then CD3 expressing T-cells (C). The stimulation of the T-cells were measured using intracellular—PE Ki-67 (D). Buffer was added to the negative control (unstimulated) in (D). The positive control in (E) was pokeweed mitogen. The stimulation of the T-cells can be seen in the proliferation gate (E). T-cell activation seen in the proliferation gate (F) when exposed to nucleocapsid (N) protein of SARS-CoV2. T-cell activation seen in the proliferation gate (G) when exposed to spike (S) protein of SARS-CoV2. SSC, side scatter.
    Figure Legend Snippet: Flow cytometric gating strategies used to identify the response of T-cells to the N-protein and S-protein of SARS-CoV2. Gating was first set on singlet events (A), followed by gating on target populations, leucocytes (B) and then CD3 expressing T-cells (C). The stimulation of the T-cells were measured using intracellular—PE Ki-67 (D). Buffer was added to the negative control (unstimulated) in (D). The positive control in (E) was pokeweed mitogen. The stimulation of the T-cells can be seen in the proliferation gate (E). T-cell activation seen in the proliferation gate (F) when exposed to nucleocapsid (N) protein of SARS-CoV2. T-cell activation seen in the proliferation gate (G) when exposed to spike (S) protein of SARS-CoV2. SSC, side scatter.

    Techniques Used: Expressing, Negative Control, Positive Control, Activation Assay



    Similar Products

    flow cytometric lymphocyte proliferation test method  (Ampath Laboratories)
    90
    Ampath Laboratories flow cytometric lymphocyte proliferation test method
    Flow <t>cytometric</t> gating strategies used to identify the response of T-cells to the N-protein and S-protein of SARS-CoV2. Gating was first set on singlet events (A), followed by gating on target populations, leucocytes (B) and then CD3 expressing T-cells (C). The stimulation of the T-cells were measured using intracellular—PE Ki-67 (D). Buffer was added to the negative control (unstimulated) in (D). The positive control in (E) was pokeweed mitogen. The stimulation of the T-cells can be seen in the <t>proliferation</t> gate (E). T-cell activation seen in the proliferation gate (F) when exposed to nucleocapsid (N) protein of SARS-CoV2. T-cell activation seen in the proliferation gate (G) when exposed to spike (S) protein of SARS-CoV2. SSC, side scatter.
    Flow Cytometric Lymphocyte Proliferation Test Method, supplied by Ampath Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/flow+cytometric+lymphocyte+proliferation+test+method/pmc08783969-63-2-13?v=Ampath+Laboratories
    Average 90 stars, based on 1 article reviews
    flow cytometric lymphocyte proliferation test method - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Flow cytometric gating strategies used to identify the response of T-cells to the N-protein and S-protein of SARS-CoV2. Gating was first set on singlet events (A), followed by gating on target populations, leucocytes (B) and then CD3 expressing T-cells (C). The stimulation of the T-cells were measured using intracellular—PE Ki-67 (D). Buffer was added to the negative control (unstimulated) in (D). The positive control in (E) was pokeweed mitogen. The stimulation of the T-cells can be seen in the proliferation gate (E). T-cell activation seen in the proliferation gate (F) when exposed to nucleocapsid (N) protein of SARS-CoV2. T-cell activation seen in the proliferation gate (G) when exposed to spike (S) protein of SARS-CoV2. SSC, side scatter.

    Journal: Journal of Clinical Pathology

    Article Title: Comparison of T-cell immune responses to SARS-CoV-2 spike (S) and nucleocapsid (N) protein using an in-house flow-cytometric assay in laboratory employees with and without previously confirmed COVID-19 in South Africa: nationwide cross-sectional study

    doi: 10.1136/jclinpath-2021-207556

    Figure Lengend Snippet: Flow cytometric gating strategies used to identify the response of T-cells to the N-protein and S-protein of SARS-CoV2. Gating was first set on singlet events (A), followed by gating on target populations, leucocytes (B) and then CD3 expressing T-cells (C). The stimulation of the T-cells were measured using intracellular—PE Ki-67 (D). Buffer was added to the negative control (unstimulated) in (D). The positive control in (E) was pokeweed mitogen. The stimulation of the T-cells can be seen in the proliferation gate (E). T-cell activation seen in the proliferation gate (F) when exposed to nucleocapsid (N) protein of SARS-CoV2. T-cell activation seen in the proliferation gate (G) when exposed to spike (S) protein of SARS-CoV2. SSC, side scatter.

    Article Snippet: A standardised, in-house flow cytometric lymphocyte proliferation test method currently in use at Ampath to detect T-cell responses to other recall antigens, for example, Varicella-Zoster-Virus (VZV), Candida albicans and Tetanus toxoid was modified for the purpose of this study.

    Techniques: Expressing, Negative Control, Positive Control, Activation Assay